How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review

Esdonk, M.J. van; Zutphen, E.J.M. van; Roelfsema, F.; Pereira, A.M.; Graaf, P.H. van der; Biermasz, N.R.; ... ; Burggraaf, J. (2018)

Article / Letter to editor

• Acromegaly
• Growth hormone
• Pituitary adenoma
• IGF-1-review

• All authors: Esdonk, M.J. van; Zutphen, E.J.M. van; Roelfsema, F.; Pereira, A.M.; Graaf, P.H. van der; Biermasz, N.R.; Stevens, J.; Burggraaf, J.
• Date: 2018-06-30
• Journal: Pituitary
• Volume: 21
• Issue: 3
• Pages: 310 - 322
• DOI: doi:10.1007/s11102-018-0884-4
• Link: https://link.springer.com/content/pdf/10.1007/s11102-018-0884-4.pdf